Drugmaker Eli Lilly & Co is announcing a temporary shortage of two of its insulin products. "The 10 mL [millilter] vials of ...

Heading into fiscal 2025, CEO David Ricks said the company expects sales of weight-loss drugs will continue growing, and noted that it expects "to produce at least 60% more salable doses" of the drugs ...

The Food and Drug Administration has finalized its decision to call an end to the drug shortage of Eli Lilly's (LLY) blockbuster GLP-1 products, often referred to by their formula name ...

Eli Lilly And Co (NYSE:LLY) revealed on Thursday that it has identified bacteria and elevated impurity levels in products falsely claiming to be compounded versions of tirzepatide, the active ...

The United States Food and Drug Administration says the shortage of Eli ... Lilly has provided to FDA demonstrate that Lilly’s supply is currently meeting or exceeding demand for these drug ...

Eli Lilly & Co (LLY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Geoff Meacham ...